Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)
Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of ...
CrowdStrike: Toxic Trifecta Forces A Temporary Downgrade To Sell
CrowdStrike faces headwinds like SEC probes and weak guidance. Read why CRWD stock is downgraded to Sell, with sideways ...
Stifel Nicolaus Sticks to Their Hold Rating for Fate Therapeutics (FATE)
In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Hold rating on Fate Therapeutics (FATE – Research Report), with ...
Okta (NASDAQ:OKTA) Reaches New 12-Month High Following Analyst Upgrade
Okta, Inc. (NASDAQ:OKTA – Get Free Report)’s share price reached a new 52-week high on Wednesday after Stifel Nicolaus raised their price target on the stock from $115.00 to $120.00. Stifel Nicolaus ...
Gabi Nicastro Named To ANNIKA Award Watch List
Samford sophomore Gabi Nicastro has been named to the watch list for the prestigious ANNIKA Award, presented by Stifel and ...